Description
PharmaQo Anadrol 50 provides 50 mg Oxymetholone per oral tablet, presented in a 60-tablet pouch for research use. Oxymetholone is widely studied for its potent anabolic activity, erythropoiesis-stimulating effects, and applications in severe anemia models and tissue-wasting research.
In research, oxymetholone is evaluated for improving nitrogen balance, enhancing red blood cell production, and supporting investigational recovery models.
Product Details:
Active Ingredient:
-
Oxymetholone (Anadrol)
Concentration: 50 mg per tablet
Form: Oral tablets
Packaging: 60 tablets per pouch
Pharmacokinetics:
Oxymetholone has an oral half-life of ~9 hours, requiring daily or divided dosing in investigational protocols.
Usage Recommendations:
-
Indications (Research Context): Investigational use in anemia models, anabolic activity research, nitrogen retention studies (not approved for human use)
-
Typical Dosage (Research Use): 25–100 mg per day, depending on research design
-
Monitoring: Liver enzymes, lipid profile, cardiovascular health, androgenic markers
-
Cycle/Duration: Typically 4–6 weeks under research protocols
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always follow local research laws and ethical guidelines.